DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zheng SL, Roddick AJ, Aghar-Jaffar R. et al.
Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A Systematic Review and Meta-analysis.
JAMA 2018;
319 (15) 1580-1591
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.